Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA site-wide NIH announcement about terminology appears above the 403 error page, and the site revision number changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check34 days agoChange DetectedThe site footer's revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page now displays a 403 Forbidden error instead of showing the study content, indicating access is blocked to the NCT03157128 record. This reflects an access-control issue rather than an update to the study data.SummaryDifference23%

- Check55 days agoChange DetectedThe page's revision label updated from v3.6.6 to v3.7.0, indicating an updated version of the page. This is an administrative update rather than a substantive content change.SummaryDifference0.0%

- Check69 days agoChange DetectedA new revision tag, v3.6.6, appears, replacing the prior v3.6.5, indicating a minor update to the page's versioning.SummaryDifference0.0%

Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.